BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/8/2022 7:44:25 AM | Browse: 192 | Download: 409
Publication Name World Journal of Clinical Cases
Manuscript ID 77544
Country/Territory Brazil
Received
2022-05-05 21:46
Peer-Review Started
2022-05-05 21:48
To Make the First Decision
Return for Revision
2022-06-16 02:47
Revised
2022-07-10 21:20
Second Decision
2022-08-29 04:00
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-08-30 22:37
Articles in Press
2022-08-30 22:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
2022-10-18 13:19
Typeset the Manuscript
2022-10-25 05:51
Publish the Manuscript Online
2022-11-08 07:44
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Pharmacology & Pharmacy
Manuscript Type Opinion Review
Article Title Combined use of lactoferrin and vitamin D as a preventive and therapeutic supplement for SARS-CoV-2 infection: Current evidence
Manuscript Source Invited Manuscript
All Author List Massimiliano Cipriano, Enzo Ruberti and Marcos Roberto Tovani-Palone
ORCID
Author(s) ORCID Number
Enzo Ruberti http://orcid.org/0000-0002-1609-5492
Marcos Roberto Tovani-Palone http://orcid.org/0000-0003-1149-2437
Funding Agency and Grant Number
Corresponding Author Marcos Roberto Tovani-Palone, PhD, Academic Research, Department of Pathology and Legal Medicine , Ribeirão Preto Medical School, University of São Paulo, 3900 Bandeirantes Ave, Ribeirão Preto 14049-900, Brazil. marcos_palone@hotmail.com
Key Words Lactoferrin; Vitamin D; SARS-CoV-2; COVID-19; Pandemics
Core Tip The combined use of lactoferrin, using a nasal spray formulation in association with its oral intake, and vitamin D could represent, through a synergistic action, a valuable therapy for COVID-19 treatment and prevention.
Publish Date 2022-11-08 07:44
Citation Cipriano M, Ruberti E, Tovani-Palone MR. Combined use of lactoferrin and vitamin D as a preventive and therapeutic supplement for SARS-CoV-2 infection: Current evidence. World J Clin Cases 2022; 10(32): 11665-11670
URL https://www.wjgnet.com/2307-8960/full/v10/i32/11665.htm
DOI https://dx.doi.org/10.12998/wjcc.v10.i32.11665
Full Article (PDF) WJCC-10-11665.pdf
Full Article (Word) WJCC-10-11665.docx
Manuscript File 77544_Auto_Edited-LM_Kerr C_Clear Copy.docx
Answering Reviewers 77544-Answering reviewers.pdf
Audio Core Tip 77544-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 77544-Conflict-of-interest statement.pdf
Copyright License Agreement 77544-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 77544-Language certificate.pdf
Peer-review Report 77544-Peer-review(s).pdf
Scientific Misconduct Check 77544-Bing-Liu JH-2.jpg
Scientific Misconduct Check 77544-CrossCheck.jpg
Scientific Editor Work List 77544-Scientific editor work list.pdf